
About BionIT Labs
Data last updated:
BionIT Labs is a company based in Lecce (Italy) founded in 2018 by Giovanni Antonio Zappatore, Federico Gaetani, and Matteo Aventaggiato. BionIT Labs has raised $5.94 million across 3 funding rounds from investors including European Union, SEFEA IMPACT and CDP Venture Capital. BionIT Labs offers products and services including Adam's Hand, MyoLogic App, and Adam's Skin. BionIT Labs operates in a competitive market with competitors including Myomo, Proteor, BionicM, CIONIC and Epica International, among others.
- Headquarter Lecce, Italy
- Founders Giovanni Antonio Zappatore, Federico Gaetani, Matteo Aventaggiato
- SectorsHealthcare
- EmailLocked
- PhoneLocked
- WebsiteLocked
- SocialLocked
- Legal Name Bionit Labs S.R.L.
- Annual RevenueNot available
- Net ProfitNot available
- EBITDANot available
- Total Equity Funding$5.94 M (USD)
in 3 rounds
- Latest Funding Round$5.94 M (USD), Series A
Jul 05, 2024
- InvestorsEuropean Union
& 6 more
- Employee CountNot available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BionIT Labs
BionIT Labs offers a comprehensive portfolio of products and services, including Adam's Hand, MyoLogic App, and Adam's Skin.
Adaptive bionic hand for automatic grip and natural control.
App for device calibration and remote firmware updates.
IP67 glove for enhanced protection of bionic hands.
People of BionIT Labs
Unlock access to complete
Funding Insights of BionIT Labs
BionIT Labs has successfully raised a total of $5.94M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5.94 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BionIT Labs
BionIT Labs has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, SEFEA IMPACT and CDP Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and fund of funds focused on multiple sectors | Locked | Locked | Locked | |
- | Locked | Locked | Locked | |
Government agency and accelerator focusing on innovative startups and SMEs | Locked | Locked | Locked |
Investor details for BionIT Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BionIT Labs
Investment portfolio details for BionIT Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BionIT Labs
Detailed financials for BionIT Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bionit Labs Comparisons
Peer comparison for BionIT Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BionIT Labs
BionIT Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Myomo, Proteor, BionicM, CIONIC and Epica International, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked | Robotic arms are provided for mobility and rehabilitation support. | |
| Locked | Locked | Locked | Prostheses and orthoses devices are developed for orthopedic supports. | |
| Locked | Locked | Locked | Prosthetic legs assisting knee and ankle movements are developed. | |
| Locked | Locked | Locked | Bionic clothing is provided for mobility impairment support. | |
| Locked | Locked | Locked | Provider of robotic CT platforms for healthcare and industrial applications | |
| Locked | Locked | Locked | AI-powered exoskeletons and gait tools are developed for mobility recovery. |
Detailed competitors of BionIT Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bionit Labs
Complete news archive for BionIT Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BionIT Labs
BionIT Labs was founded in 2018 and raised its 1st funding round 1 year after it was founded.
BionIT Labs is headquartered in Lecce, Italy. It is registered at Lecce, Puglia, Italy.
Giovanni Antonio Zappatore is the current CEO of BionIT Labs. They have also founded this company.
BionIT Labs is a funded company, having raised a total of $5.94M across 3 funding rounds to date.
BionIT Labs was founded in 2018 in Lecce, Italy, within the bionics and prosthetics sector. Proprietary technology is utilized by the company to create myoelectric and robotic prosthetic hands. The initial product, Adams Hand, is a patent-pending device that enables actuation of five fingers through 15 degrees of freedom, one per phalanx. Operations focus on addressing needs of individuals with limb disabilities via advanced electromyography-based controls.
BionIT Labs's top competitors include Myomo, BionicM and Epica International.
BionIT Labs offers Adam's Hand, MyoLogic App, and Adam's Skin.
BionIT Labs has 7 investors. Key investors include European Union, SEFEA IMPACT, CDP Venture Capital, Simest, and ENEA Tech e Biomedical.












